TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ZVRA

Zevra Therapeutics Inc.

Healthcare · Biotechnology

11.30$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

Zevra Therapeutics Inc. (ZVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -1.6 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZVRA
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-4.4 -4.3 -15 -20 -30 -33 -54 -24 -1.9 10 -19 -34 -70 -1.6
0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.3 0.3 0.3 0.9 1.0 6.4 4.1
0.5 0.1 0.2 2.4 6.6 4.6 6.5 4.4 2.5 2.4 4.3 6.0 15 13
– – – – – – – 3.8 7.9 19 22 – – –
– 0.1 1.5 0.1 3.3 -1.7 -2.3 -5.1 0.4 -0.4 -0.4 5.9 -6.6 -27
0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8
5.0 0.0 0.0 -19 -47 27 33 3.2 0.0 -16 -37 -17 -22 18
– – – – – – – – – 31 0.3 – – –
-0.1 – – – – – – – 0.0 -2.8 -4.7 -3.4 0.0 –
– – – – – – – -0.2 0.6 -38 13 25 16 0.0
0.4 3.8 23 61 61 -0.2 28 4.9 2.7 113 8.4 28 82 12
2.5 -0.6 8.3 22 -16 -5.9 7.1 -16 0.8 108 -47 -22 -9.3 29
-4.5 -4.4 -15 -20 -30 -33 -54 -24 -2.0 10 -19 -34 -70 -2.4

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?